Use access key #2 to skip to page content.
$66.97 0.08 (0.12%)
10/7/2008 3:45 PM

ImClone Systems, Inc. (IMCL)

CAPS Rating:
**

A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.

View All Commentary (IMCL)

Recs

0

Avatar RBBioContest06 (41.69) Submitted: 5/31/06 10:46 PM : Outperform Start Price: $39.84 IMCL Score: 89.58

Picked by 5starJ

Report this Post Replies: 0 | Reply

Featured Broker Partners